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Introduction

Ca
2+ signals within cells are spatially and temporally intricate, allowing them to elicit a multitude of specific downstream effects (Berridge, 2009 (Foskett et al. 2007; Taylor & Tovey, 2010 (Smith & Parker, 2009 ). This in turn plays a key role in defining the spatial organization of IP 3 -evoked Ca 2+ signals. Activation of IP 3 Rs is initiated by binding of IP 3 within a clam-like structure, the IP 3 -binding core (IBC) (Bosanac et al. 2002) , located near the N-terminus of each IP 3 R subunit. Binding of IP 3 causes a conformational change that rearranges the association of the IBC with the N-terminal suppressor domain (SD). These changes are proposed to disrupt interactions between the N-terminal regions of the four subunits of the IP 3 R, leading to opening of the channel. The latter is formed by transmembrane domains (TMDs) towards the C-terminus of each IP 3 R subunit (Seo et al. 2012) (Fig. 1 linking binding of IP 3 to channel gating. One possibility is that the conformational changes evoked by binding of IP 3 expose a site to which Ca 2+ must bind before the channel can open (Marchant & Taylor, 1997; Foskett et al. 2007) . However, neither the structural identity of this stimulatory Ca 2+ -binding site, nor that of the inhibitory site through which higher concentrations of Ca 2+ inhibit IP 3 Rs have been resolved. The inhibitory site may reside on an accessory protein associated with IP 3 Rs.
IP 3 Rs are present in almost all animal cells and some protozoa (Prole & Taylor, 2011) , but there are no homologous proteins in plants (Wheeler & Brownlee, 2008) or fungi (Prole & Taylor, 2012) . The genomes of vertebrates encode three subtypes of IP 3 R subunit (IP 3 R1-3), which can form homo-tetrameric or hetero-tetrameric channels (Joseph et al. 1995) with differing properties and distributions (Foskett et al. 2007; Mikoshiba, 2007) . In mammalian cells, IP 3 Rs have been reported to release Ca 2+ mainly from the endoplasmic reticulum (ER) (Streb et al. 1984; Volpe et al. 1985) , but the Golgi apparatus (Pinton et al. 1998 ) and secretory vesicles (Yoo, 2011) from the ER (Parekh & Putney, 2005; Lewis, 2012) . Ca 2+ signals initiated by IP 3 Rs evoke a wide variety of cellular events, ranging from embryological development (Kume et al. 1997; Uchida et al. 2010) to cellular metabolism (Cardenas et al. 2010) , gluconeogenesis , exocrine secretion (Futatsugi et al. 2005 ) and neuronal function (Matsumoto et al. 1996) . Specificity within Ca 2+ signalling pathways, or indeed any signalling pathway (Scott & Pawson, 2009; Scott et al. 2013) , is achieved, in part, by the formation of macromolecular signalling complexes. Within the signalling pathways that involve phospholipase C (PLC), these complexes regulate the activity of IP 3 Rs, their distribution, and their association with both the plasma membrane receptors that evoke IP 3 formation and the downstream targets of the Ca 2+ released by IP 3 Rs (Konieczny et al. 2012) . The interactions of IP 3 Rs with other proteins have been reviewed previously (Choe & Ehrlich, 2006; Foskett et al. 2007; Mikoshiba, 2007; Vanderheyden et al. 2009a ), but continued progress and the advent of high-throughput proteomics methods (Havugimana et al. 2012; Rolland et al. 2014) suggest that an update is timely.
Searches of proteomic databases and published literature reveal a large number of proteins that form complexes with IP 3 Rs (Tables 1-4). For some of these proteins, the regions within IP 3 Rs that are important for the interaction have been mapped (Fig. 1) . At the outset, it is worth sounding some notes of caution regarding Data for Tables 1-4 were derived from manual searches of the literature, reviews (Choe & Ehrlich, 2006; Foskett et al. 2007; Mikoshiba, 2007; Vanderheyden et al. 2009a ) and databases, including BioGRID (Chatr-Aryamontri et al. 2015) and IntAct (Orchard et al. 2013 Table 2 ); direct activation seems to occur only transiently, and is controversial. (Ando et al. 2014) . Secondly, the interactions and their effects may depend on the cellular context, including such factors as the subtype of IP 3 R, the physiological status of the IP 3 R (e.g. phosphorylation), the cell type and the expression levels of the interacting proteins and IP 3 Rs. Thirdly, interactions that occur in cellular lysates may be precluded within intact cells. For example, the interaction of two proteins may be prevented by their physical separation within the cell or by mutually exclusive binding of other proteins or ligands. IRBIT, for example, binds to IP 3 R subunits only when they have no IP 3 bound. Lastly, some forms of experimental evidence are more discriminating than others, and it will be necessary to verify the putative interactions indicated by methods such as yeast two-hybrid screening and mass spectrometry. Although we focus on the ability of IP 3 Rs to release Ca 2+ from intracellular stores, IP 3 Rs have additional roles. For example, binding of IP 3 is proposed to release IRBIT from the IP 3 -binding site, freeing IRBIT to regulate additional targets that include ion channels, transporters and the enzyme ribonucleotide reductase (Ando et al. 2014; Arnaoutov & Dasso, 2014) . IP 3 Rs may also regulate associated proteins independently of their ability to release Ca 2+ . For example, a direct interaction between IP 3 Rs and TRPC (transient receptor potential canonical) channels is proposed to stimulate opening of the latter . Hence, when reviewing the effects of proteins associated with IP 3 Rs, we should look beyond entry, and effects unrelated to Ca 2+ signalling. That scope is too ambitious for this short review. Instead we provide a comprehensive summary of proteins suggested to interact with IP 3 Rs (Tables 1-4 , within which we provide most references) and then explore a few selected examples to illustrate some general features.
Signalling complexes containing IP 3 Rs span entire signalling pathways
The sheer number of proteins reported to form complexes with IP 3 Rs is striking and so too is their diversity, in terms of both cellular geography and function (Tables 1-4) . IP 3 Rs form complexes with many of the proteins that link extracellular stimuli to formation of IP 3 , including G protein-coupled receptors (GPCRs), the epidermal growth factor receptor (EGFR), the erythropoietin receptor, the Gβγ complexes of G proteins, and some forms of PLC. IP 3 Rs also associate with other signalling proteins linked to PLC signalling, including protein kinase C (PKC), RACK1 (receptor of activated PKC) and the phosphoinositide phosphatase PTEN. The interactions extend also to proteins from other signalling pathways, including adenylyl cyclase (AC), the small G protein K-Ras, and the protein kinases AKT1 (RAC-α serine/threonine protein kinase), mTOR (mammalian target of rapamycin), c-Src and MAPK1/MAPK3 (mitogen-activated protein kinase 1/3) (Tables 1-4 and Fig. 1 ). Proteins that respond to the Ca 2+ released by IP 3 Rs also form complexes with IP 3 Rs. These include ion channels, exchangers and pumps within the plasma membrane. It is clear that IP 3 Rs reside within macromolecular complexes that both span entire signalling pathways from cell-surface receptors to the effectors that respond to Ca 2+ , and include proteins that integrate signals from other signalling pathways.
The advantages of these signalling complexes are clear. They allow information to be directed selectively from specific extracellular stimuli to specific intracellular targets through conserved signalling pathways. Furthermore, associated proteins can integrate signals from different signalling pathways and so modulate traffic through the complex. Hence, protein complexes confer both specificity and plasticity. A third advantage is speed. Signalling pathways must be able to turn on and off quickly. Fast activation benefits from high concentrations of reactants and fast on-rates (k 1 ) for association of messengers with their targets. Rapid de-activation requires rapid destruction or dissipation of the messenger and a fast dissociation rate (k −1 ). By facilitating delivery of messengers at high local concentrations to their targets (e.g. IP 3 to IP 3 Rs), signalling complexes contribute to both rapid activation and de-activation, the latter because diffusion of messengers away from the site of delivery may be sufficient to allow their concentration to fall below that required for activation as soon as synthesis of the messenger ceases. Secondly, targets can have fast off-rates (k −1 ) with a corresponding loss of affinity (equilibrium association constant, K A = k 1 /k −1 ) that does not compromise their capacity to respond to high local concentrations of messenger. We suggest, then, that assembly of proteins around IP 3 Rs contributes to fast and specific signalling, while providing opportunities for signal integration and plasticity.
For convenience, we consider the proteins that associate with IP 3 Rs under four somewhat arbitrary (and overlapping) headings: proteins that enhance or inhibit the J Physiol 594.11 (Muller et al. 2011) , synaptic dysfunction and neuronal degeneration (Mattson, 2010) .
Although activation of IP 3 Rs normally requires binding of IP 3 and Ca 2+ , a few proteins have been reported to cause reversible activation of IP 3 Rs directly, without the coincident presence of IP 3 and Ca 2+ (Table 1) . These include Gβγ (Zeng et al. 2003) , CIB1 (White et al. 2006) and, more controversially, CaBP1 (Yang et al. 2002) . The initial report on the actions of CaBP1 described an activation of Xenopus IP 3 Rs in the absence of IP 3 in vitro.
However, subsequent studies have demonstrated that CaBP1 inhibits Ca 2+ release via mammalian and Xenopus IP 3 Rs by stabilizing an inactive state of the IP 3 R (Haynes et al. 2004; Nadif Kasri et al. 2004; White et al. 2006; Li et al. 2013) . Similarly, CIB1 was reported to activate IP 3 Rs in Xenopus oocytes and Sf9 insect cells in the absence of IP 3 , but it too inhibits Ca 2+ release via mammalian IP 3 Rs (White et al. 2006) . Uniquely, an irreversible activation of IP 3 Rs appears to occur after proteolytic cleavage by caspase-3 (Assefa et al. 2004; Nakayama et al. 2004 ), a process that may play a prominent role in apoptosis.
Proteins that inhibit the function of IP 3 Rs
Many proteins that interact with IP 3 Rs inhibit their function (Table 2 ). These interactions may enable rapid feedback regulation of Ca 2+ release and provide long-term attenuation of IP 3 R activity by promoting degradation or irreversible inhibition of IP 3 Rs. These mechanisms J Physiol 594.11 contribute to the tight regulation of IP 3 R activity needed to achieve spatial and temporal organization of Ca 2+ signals (Konieczny et al. 2012) . They also provide protection from the damaging consequences of excessive increases in cytosolic free Ca 2+ concentration (Orrenius et al. 2015) and disturbance of the other essential roles of the ER while it fulfils its role in Ca 2+ signalling (Berridge, 2002) Table 2) .
IRBIT inhibits all three IP 3 R subtypes by competing with IP 3 for binding to the IBC . IRBIT binds only when it is phosphorylated at several sites, probably because the phosphorylated residues mimic the essential phosphate groups of IP 3 ( Fig. 2A) . Residue S68 is the 'master' phosphorylation site. When it is Phosphorylation of S68, the 'master' phosphorylation site, allows sequential phosphorylation of the two residues, S71 and S74, that must be phosphorylated for IRBIT to bind to IP 3 Rs. Protein phosphatase 1 (PP1) bound to IRBIT dephosphorylates S68. B, phosphorylation of IRBIT (1) allows it to bind to the IBC and so compete with IP 3 for binding to the IP 3 R. Phospho-IRBIT thereby sets the sensitivity of the IP 3 R to IP 3 . IP 3 binding to the IBC (2) prevents IRBIT binding and initiates activation of the IP 3 R. The displaced phospho-IRBIT can regulate many additional targets, including ion channels and transporters (3). The Ca 2+ released by active IP 3 Rs may control the phosphorylation state of IRBIT, and thereby complete a feedback loop that regulates IP 3 R sensitivity (4).
phosphorylated by a Ca 2+ -dependent kinase, perhaps a Ca 2+ /calmodulin-dependent protein kinase (CaMK), it allows casein kinase I-mediated phosphorylation of the two residues (S71 and S74, residue numbering relates to mouse IP 3 R1) that are critical for binding of IRBIT to IP 3 Rs (and its other targets) (Ando et al. 2014) . Dephosphorylation of S68 is catalysed by protein phosphatase 1 (PP1), which also associates with IRBIT. The competition between phospho-IRBIT and IP 3 for occupancy of the IBC through which IP 3 initiates activation of IP 3 Rs allows IRBIT to tune the sensitivity of IP 3 Rs to IP 3 . Hence, inhibiting expression of IRBIT, or expression of a dominant negative form (IRBIT-S68A), allows Ca 2+ release at lower concentrations of IP 3 (Ando et al. 2014) . This tuning of IP 3 R sensitivity has been demonstrated in sympathetic neurons where, as discussed earlier, M 1 Rs do not associate with IP 3 Rs and do not normally generate sufficient IP 3 to activate more distant IP 3 Rs (Delmas et al. 2002) . However, expression of the dominant negative IRBIT allows M 1 Rs to evoke Ca 2+ release through IP 3 Rs (Zaika et al. 2011) . Although the details are not fully resolved, the interplay between Ca 2+ and the activation of IRBIT is intriguing because it suggests potential feedback loops that might control the sensitivity of IP 3 Rs to IP 3 (Ando et al. 2014) . The phosphorylation (of S68) that initiates activation of IRBIT is Ca 2+ sensitive, deactivation of IRBIT by proteolytic cleavage within its N-terminal may be mediated by Ca 2+ -sensitive calpain, and IRBIT itself inhibits Ca 2+ /calmodulin-dependent protein kinase IIα (CaMKIIα) (Kawaai et al. 2015) (Fig. 2B) .
Post-translational modification of IP 3 Rs by associated proteins may be reversible (e.g. phosphorylation) (Betzenhauser & Yule, 2010) or irreversible (e.g. proteolysis and some covalent modifications). An example of the latter is the Ca 2+ -dependent enzyme transglutaminase type 2 (TGM2). By covalently modifying a glutamine residue within the C-terminal tail of IP 3 R1, TGM2 causes irreversible cross-linking of adjacent IP 3 R subunits via a lysine residue and the modified glutamine. This prevents the conformational changes required for activation of IP 3 Rs, and so inhibits IP 3 -evoked Ca 2+ release (Hamada et al. 2014) . The Ca 2+ sensitivity of TGM2 may allow it to contribute to feedback control of Ca 2+ release and to disruption of IP 3 R function when dysregulation of Ca 2+ signalling occurs in pathological conditions such as Huntington's disease (Hamada et al. 2014) . Activation of IP 3 Rs and the ensuing release of Ca 2+ also trigger ubiquitination and proteasomal degradation of IP 3 Rs (Pearce et al. 2009 ) and their cleavage by calpains (Magnusson et al. 1993; Wojcikiewicz & Oberdorf, 1996) . Hence, proteins that associate with IP 3 Rs provide mechanisms that allow both acute and long-term feedback regulation of IP 3 R activity.
Downstream effectors
IP 3 Rs also form complexes with proteins that are downstream effectors of IP 3 R activation; most of these respond to the Ca 2+ released by IP 3 Rs (Table 3) . Many of these proteins are cytosolic, but others reside within membranes that allow IP 3 Rs within the ER to communicate with other intracellular organelles or the plasma membrane. The importance of this communication between organelles, mediated by junctional complexes between them, is increasingly recognized (Lam & Galione, 2013) .
Hepatic gluconeogenesis, which is likely to play an important role in diabetes and obesity, is stimulated by glucagon released by the pancreas during fasting, and inhibited by insulin released when the plasma glucose concentration increases. A complex containing IP 3 Rs, the Ca 2+ -regulated protein phosphatase calcineurin, the transcriptional co-activator of CREB-regulated transcription CRTC2 (CREB-coactivator C2), PKA and AKT1 coordinates gluconeogenesis (Fig. 3) . De-phosphorylated CRTC2 binds to nuclear CREB and up-regulates genes that promote gluconeogenesis. This is repressed by SIK2, a kinase that phosphorylates CRTC2. IP 3 -evoked Ca 2+ release activates calcineurin, which de-phosphorylates CRTC2. Glucagon receptors stimulate production of both cAMP and IP 3 (Wakelam et al. 1986; Wang et al. 2012) . The cAMP activates PKA, which phosphorylates, and thereby inhibits, SIK2; and it phosphorylates IP 3 Rs, sensitizing them to activation by IP 3 and Ca 2+ . IP 3 Rs are also directly sensitized by cAMP (Tovey et al. 2008) . Increased release of Ca 2+ via IP 3 Rs activates calcineurin, which dephosphorylates CRTC2 (Vanderheyden et al. 2009a; Wang et al. 2012) . Hence glucagon both inhibits the kinase (SIK2) and stimulates the phosphatase (calcineurin) that control phosphorylation of CRTC2. Glucagon also reduces binding of CRTC2 to IP 3 Rs , further enhancing the nuclear translocation of dephosphorylated CRTC2. The signals evoked by insulin receptors also feed into this IP 3 R complex. Glucagon and insulin exert opposing effects on hepatic gluconeogenesis. Their signalling pathways converge to a protein complex assembled around IP 3 Rs, the activity of which controls phosphorylation of the transcription factor CRTC2. Dephosphorylated CRTC2 translocates to the nucleus, where it associates with CREB and stimulates transcription of genes required for gluconeogenesis. SIK2 phosphorylates CRTC2, while calcineurin dephosphorylates it. Glucagon, via a GPCR, stimulates both PLC and AC. The IP 3 produced by PLC stimulates IP 3 Rs. The cAMP generated by AC stimulates PKA and that promotes dephosphorylation of CRTC2 by phosphorylating both SIK2 (inhibiting its activity) and IP 3 Rs, sensitizing the latter to IP 3 . The larger Ca 2+ signal then activates calcineurin. Insulin causes activation of AKT1, which phosphorylates IP 3 Rs and inhibits their activity; it thereby opposes the effects of glucagon and attenuates calcineurin activity. Phosphorylation is indicated by red circles, black arrows denote stimulation and the red arrow denotes inhibition. Abbreviations and further details in the text and tables.
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Insulin stimulates phosphatidylinositol 3-kinase (PI3K) and thereby AKT1. The latter phosphorylates IP 3 Rs and attenuates their activity. Hence insulin, by inhibiting IP 3 Rs, opposes the actions of glucagon by restraining the activation of calcineurin and so maintains CRTC2 in its inactive phosphorylated state . This example illustrates some of the intricate interactions that the assembly of proteins around IP 3 Rs can allow: signals from a GPCR and a receptor tyrosine kinase converge at IP 3 Rs, which then integrate the inputs and transduce them into a regulation of gene expression (Fig. 3) .
Proteins that determine the distribution of IP 3 Rs
The subcellular distribution of IP 3 Rs is an important influence on their behaviour, not least because it defines the sites at which they will release Ca 2+ , and whether they will be exposed to effective concentrations of the stimuli that activate them, IP 3 (Tateishi et al. 2005; Rahman et al. 2009; and see references in Geyer et al. 2015) , although the role of this process in shaping Ca 2+ signals remains controversial (Smith et al. 2014) . We have suggested that IP 3 -evoked clustering of IP 3 Rs may contribute to the coordinated openings of IP 3 Rs that underlie the small Ca 2+ signals ('Ca 2+ puffs') evoked by low stimulus intensities, by both bringing IP 3 Rs together and retuning their Ca 2+ sensitivity (Rahman et al. 2009 ). Head-to-head interactions of IP 3 Rs have also been observed in electron micrographs of purified IP 3 Rs (Hamada et al. 2003) , between opposing ER membranes within cells (Takei et al. 1994) and between the isolated N-terminal domains of IP 3 Rs (Chavda et al. 2013) . The functional significance of these interactions has not been established.
A recent study of the Ca 2+ signals evoked by thrombin-mediated stimulation of the protease-activated receptor PAR-1 in endothelial cells provides evidence that microtubules may guide IP 3 Rs into the clusters within which Ca 2+ release can most effectively recruit neighbouring IP 3 Rs (Geyer et al. 2015) . In lung microvascular endothelial cells, thrombin, which activates PAR-1 by cleaving its N-terminal, stimulates PLC and thereby evokes Ca 2+ release through IP 3 Rs. The resulting increase in cytosolic Ca 2+ concentration contributes to disassembly of the adherens junctions that maintain the integrity of the endothelium (Komarova & Malik, 2010 any residue) (Honnappa et al. 2009 (Fig. 4) . We conclude that association of IP 3 Rs with other proteins, components of the PLC signalling pathway or EB3, contributes to effective delivery of the two essential regulators of IP 3 Rs, IP 3 and Ca 2+ , respectively.
Conclusions
IP 3 Rs and the Ca 2+ they release are called upon to specifically regulate many physiological processes (Berridge, 2009) , while neither perturbing the other essential roles of the ER (Berridge, 2002) nor subjecting the cell to the deleterious consequences of excessive increases in cytosolic Ca 2+ concentration (Orrenius et al. 2015) . These demands impose a need for complex regulation of IP 3 Rs, much of which is achieved by assembling proteins around IP 3 Rs to form signalling complexes (Konieczny et al. 2012) . These complexes allow signals to be directed through conserved signalling pathways and endow the pathways with speed, integrative capacity and plasticity. The very large size of IP 3 Rs relative to most other ion channels might be viewed as an evolutionary adaptation to meet this need for them to function as signalling hubs.
Advances in genomics, proteomics, antibody technologies and bioinformatics have transformed analyses of protein-protein interactions. It is now possible to interrogate these interactions on a whole-proteome scale (Havugimana et al. 2012; Rolland et al. 2014) . Bioinformatic methods can predict protein-protein interactions (Baughman et al. 2011; Kotlyar et al. 2015) and even the regions of the proteins that are involved (Gavenonis et al. 2014) . These powerful technologies, and the opportunities they provide to design new therapies (Wells & McClendon, 2007) , cannot displace the need for direct confirmation of the interactions and their functional significance. Together, these approaches pave the way to defining the properties and functional importance of IP 3 R signalling hubs in normal physiology and disease. 
